Usman, Muhammad Shariq
Van Spall, Harriette G. C.
Greene, Stephen J.
Pandey, Ambarish
McGuire, Darren K.
Ali, Ziad A.
Mentz, Robert J. http://orcid.org/0000-0002-3222-1719
Fonarow, Gregg C. http://orcid.org/0000-0002-3192-8093
Spertus, John A.
Anker, Stefan D.
Butler, Javed
James, Stefan K. http://orcid.org/0000-0003-4413-9736
Khan, Muhammad Shahzeb
Article History
Accepted: 11 April 2022
First Online: 17 May 2022
Competing interests
: H.G.C.V. is funded by the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada. S.J.G. has received research support from the Duke University Department of Medicine Chair’s Research Award, American Heart Association, Amgen, AstraZeneca, Bristol Myers Squibb, Cytokinetics, Merck, Novartis, Pfizer and Sanofi; has served on advisory boards for Amgen, AstraZeneca, Bristol Myers Squibb, Cytokinetics, Roche Diagnostics and Sanofi; and serves as a consultant for Amgen, Bayer, Bristol Myers Squibb, Merck, PharmaIN, Roche Diagnostics, Sanofi, Tricog Health, Urovant Pharmaceuticals and Vifor. D.K.M. reports honoraria for clinical trial leadership from AbbVie, Akebia, Arena, AstraZeneca, Boehringer Ingelheim, CSL Behring, Dynavax, Eidos, Esperion, Lexicon, Lilly USA, Merck & Co, Novo Nordisk, Otsuka, Pfizer and Sanofi, and honoraria for consultancy from Afimmune, Applied Therapeutics, Bayer, Boehringer Ingelheim, CSL Behring, Lilly USA, Merck & Co, Metavant, Novo Nordisk and Sanofi. Z.A.A. reports institutional research grants to Columbia University from Abbott and Cardiovascular Systems; and is a consultant for Abbott, Abiomed, AstraZeneca and Shockwave. R.J.M. reports receiving personal fees from Amgen, Bayer, Boehringer Ingelheim, Merck & Co and Novartis International; and receiving research support and honoraria from Abbott Laboratories, American Regent, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim/Eli Lilly & Co, Boston Scientific Corporation, Cytokinetics, FAST BioMedical, Gilead Sciences, Innolife, Medtronic, Merck & Co, Novartis International, Relypsa, Respicardia, Windtree Therapeutics and ZOLL Medical Corporation. G.C.F. reports research support from the National Institutes of Health and consulting for Abbott, Amgen, AstraZeneca, Bayer, Cytokinetics, Janssen, Medtronic, Merck and Novartis. J.A.S. is a consultant for Bayer, Janssen, Merck, Myokardia, Novartis, Terumo and United Healthcare; receives grant support from Janssen and Myokadia; and holds the copyright to the Peripheral Artery Questionnaire, Kansas City Cardiomyopathy Questionnaires and the Seattle Angina Questionnaire; and serves on the Board of Blue Cross/Blue Shield of Kansas City. S.D.A. declares grants or personal fees from Abbott Vascular, Actimed, Amgen, AstraZeneca, Bayer, Bioventrix, Boehringer Ingelheim, Brahms, Cardiac Dimensions, Cordio, Janssen, Occlutech, Respicardia, Servier, Vifor Int. and V-Wave. J.B. has served as a consultant for Abbott, Adrenomed, Arena Pharma, Amgen, Applied Therapeutics, Array, AstraZeneca, Bayer, Boehringer Ingelheim, Cardior, CVRx, Eli Lilly, G3 Pharma, Imbria, Impulse Dynamics, Innolife, Janssen, LivaNova, Luitpold, Medtronic, Merck, Novartis, Novo Nordisk, Sequana Medical, V-Wave Limited and Vifor. S.K.J. has received institutional research/grant support from AstraZeneca, Bayer, Janssen and Novartis. The other authors declare no competing interests.
Free to read: This content has been made available to all.